U.S. markets open in 3 hours

Ethema Health Corporation (GRST)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0057-0.0001 (-1.72%)
At close: 3:41PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0058
Open0.0056
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0052 - 0.0058
52 Week Range0.0000 - 0.0150
Volume4,422,312
Avg. Volume21,931,483
Market Cap12.938M
Beta (5Y Monthly)1.65
PE Ratio (TTM)5.70
EPS (TTM)0.0010
Earnings DateNov 16, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Ethema Acquires Larger Interest in ARIA Treatment Center
    GlobeNewswire

    Ethema Acquires Larger Interest in ARIA Treatment Center

    West Palm Beach, FL, April 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Ethema Health Corporation (OTCPINK: GRST) (“Ethema” “GRST” or the “Company”) is pleased to announce that the Company will be increasing its stake in the ARIA treatment center by executing a revised purchase option as it nears the closing of the purchase of a majority interest in the ARIA treatment facility in West Palm Beach, Florida. The ARIA facility has been become profitable and cash flow positive in the first few months of operation after it became an in-network provider to Blue Cross and Blue Shield of Florida, Inc. (“Florida Blue”). ARIA is contracted to provide services to holders of HMO policies under the Florida Blue, My Blue and other Blue Cross brands. The construction buildout of the first floor of the treatment center is underway and will soon allow for an increase to the number of beds the treatment center can provide on its second and third floors of the center. Capacity will increase from 40 to 52 beds. ARIA has hit a high occupancy of 36 beds recently and the additional beds will be needed in the near future. The Company has worked together with the Seller to create a tremendous platform for growth with the ARIA treatment center and together crafted a revision to the original agreement that gives the Company a larger share of the business and more closely aligns the interests of the Seller with the shareholders of the Company. The Company will increase its ownership in the treatment center from 51% to 75% and in addition to a payment of $50,000.00 for the added interest, the Company will issue to the Seller one hundred million shares of the Company common stock. The change of ownership requires the approval of the Florida Department of Children and Families and it is expected to close in late May, 2021. The Company will be able to report the financial operations of the center in its second quarter filings. Since the restructuring that occurred in June and July of 2020, The Company has created significant value for the shareholders and the revised agreement further increase the value to the shareholders. The Company required debt capital to fund the start-up of the new treatment center and now must turn its attention to managing the repayment of the debt while maintaining shareholder value. The Company expects to make significant progress on the debt in the coming months while it continues to grow the treatment center business. The Company announced MOU with Sparta Capital Ltd. is moving towards more definitive agreements on a structure for a joint venture to roll out a multi-faceted solution to creating safe workspaces. The ARIA treatment center has continued to have great success in the use of Covid Clear (hypochlorous acid) in the treatment of the of the working and living space at the treatment center. “We have seen first hand the effectiveness of the use of hypochlorous acid in protecting our workspace and we are excited to be part of an effort to bring this solution to other workplaces in North America,” said Company CEO Shawn Leon. “Restructuring the Company and creating a tremendous treatment center asset during the Pandemic has been a challenge. We have succeeded and are now poised to make even more significant strides as the Company and the economy start to get back to work safely.” About Ethema Health Corporation Ethema Health Corporation (OTCPINK: GRST) operates in the behavioral healthcare space specifically in the treatment of substance use disorders. Ethema developed a unique style of treatment over the last decade and has had much success with in-patient treatment for adults. Ethema will continue to develop world class programs and techniques for North America. For more information you can visit our website at www.ethemahealth.com . Notice Regarding Forward-Looking Statements The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. For information please contact: Ethema Health Corporation Text to 416-500-0020 shawn@ethemahealth.com Twitter @healthethema

  • Ethema Signs M.O.U. with Canadian based Sparta Group to Expand its Focus on its Pathogen Protection Initiatives
    GlobeNewswire

    Ethema Signs M.O.U. with Canadian based Sparta Group to Expand its Focus on its Pathogen Protection Initiatives

    West Palm Beach, FL, March 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Ethema Health Corporation (OTCPINK: GRST) (“Ethema” “GRST” or the “Company”), is collaborating with Toronto Canada based, environmental technology company, Sparta Group (“Sparta”) to expand on its efforts to enter the virus protection market. Ethema and Sparta have signed a Memorandum of Understanding (“MOU”) to form an equally owned joint venture company (the “Joint Venture”) for the purposes of manufacturing and selling products containing hypochlorous acid (“HOCI”) and to pursue the previously announced acquisition of Biohazard Health Services Ltd. Sparta is an environmental services company with expertise that lends itself to the pursuit of this business vertical. Sparta is involved in a number of pathogen protection products and has access to highly specialized manufacturers of products containing HOCl. These HOCI products have been developed over the last 25 years in the food processing industry and have been successfully used to kill bacteria in poultry and beef processing plants. This expertise will be invaluable to the Joint Venture. Sparta is also providing a suite of COVID-fighting solutions to the trucking industry, a sector they already serve, and has been quickly expanding to offer its solutions to several other industries. In light of COVID-19, keeping up with germ protection in many workplaces has been labor-intensive and time consuming. However, the COVID-Clear™ supplied Hypochlorous Acid used by Ethema was set up to disperse a pathogen attacker through airborne delivery on a constant basis, thus freeing up employees to stay focused on their jobs. The 40-bed Addiction Recovery Institute of America (ARIA) facility, located in West Palm Beach Florida, has been using an HOCI based pathogen protection system since the beginning of the worldwide COVID-19 pandemic, with great success. With concerns about a potential third wave of COVID-19 looming on both sides of the Canada-US border, the two joint venture partners have decided to explore the use of HOCI disinfectant technologies in various market verticals, including health-related and industrial manufacturing settings. Hypochlorous acid (“HOCl”) is a familiar substance to many in the food processing industry, due to the fact that it is able to fight the pathogens that run rampant when processing products. “The COVID-19 crisis has put a spotlight on the subject of harmful pathogens in general. Bacteria, spores, and viruses can be found all around us and with the right hypochlorous acid system, we believe we can prevent outbreaks from running out of control in various settings. We look forward to getting to work with Sparta,” said President and CEO of Ethema, Shawn Leon. Hypochlorous acid is a naturally occurring molecule that is an important component of the human internal defense system that demonstrates antimicrobial properties supported by both in-vitro and in-vivo studies. An important function of HOCI in host immunity is similar to that of the human immune system’s neutrophils; releasing their attack to destroy pathogenic organisms. The collective science and engineering teams explains HOCI is a fairly simple chemistry that can be produced with food grade raw materials to cause the necessary chemical reactions. By properly controlling the balance between the concentration (“PPM”), the acidity (“pH”) and the oxidation reaction potential (“ORP”) the HOCI can be produced to closely emulate the germ fighting properties the human white blood cells produce. The formulation being applied kills pathogens by tearing down the cell membranes and proteins; a process known as phagocytosis, which is one of humans’ most symbiotic actions – eliminating pathogens yet being inherently harmless. So, unlike many pathogen-fighting substances, HOCI is non-toxic and not harmful to humans. Hypochlorous acid has been cleared by the FDA and is EPA registered. Additionally, a review of HOCI published by the National Centre for Biotechnology Information states that the substance has “potential benefit to disinfect large spaces, such as medical and dental offices where aerosols can be airborne for extended periods.” “Our end goal is to be able to offer an HOCI dispersion system that inactivates bacteria, viruses, and fungi, that is safe for both humans and animals, and is easy to use in just about any market sector. We are so pleased to have our scientific teams collaborating to see how we can open up more opportunities to distribute this clean, green and safe solution,” added John O’Bireck, President of Sparta Group. About Sparta Sparta Group (a.k.a. Sparta Capital Ltd.) is a publicly traded technology-based company listed on the TSX Venture Exchange under the symbol “SAY” (TSX.V:SAY). It owns or holds a controlling interest in a network of independent businesses that supply energy saving technologies designed to reduce energy inefficiencies, achieve reduced emissions and increase operating efficiencies in various industries. In response to the COVID-19 crisis, Sparta has also expanded its scope to help facilitate supply of necessary materials while assisting talented inventors who are looking to introduce innovative technical solutions that will bring greater normalcy to the post COVID-19 world. Sparta’s network of independent businesses provides a wide range of specialized energy capturing, converting, optimizing, and related services to the commercial sector. Sparta provides capital, technical and engineering expertise, legal support, financial and accounting knowledge, strategic planning and other shared services to its independent businesses. Visit the Sparta Group website at www.spartagroup.ca About Ethema Ethema Health Corporation (OTCPINK: GRST) operates in the behavioral healthcare space specifically in the treatment of substance use disorders. Ethema developed a unique style of treatment over the last decade and has had much success with in-patient treatment for adults. Ethema will continue to develop world class programs and techniques for North America. For more information you can visit our website at www.ethemahealth.com. Notice Regarding Forward-Looking Statements The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. For information please contact: Shawn Leon, President and CEO, Ethema Text: 416-500-0020 shawn@ethemahealth.com

  • Ethema Announces Blue Cross In-Network Contract for ARIA Treatment Center
    GlobeNewswire

    Ethema Announces Blue Cross In-Network Contract for ARIA Treatment Center

    WEST PALM BEACH, FL, March 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Ethema Health Corporation (OTCPINK: GRST) (“Ethema” “GRST” or the “Company”), is pleased to announce that the ARIA treatment facility in West Palm Beach Florida has become an approved provider to New Directions Behavioral Health, LLC (“New Directions”). New Directions manages behavioral health providers for Blue Cross and Blue Shield of Florida, Inc. (“Florida Blue”). ARIA is contracted to provide services to holders of HMO policies under the Florida Blue, My Blue and other Blue Cross brands. The ability to bill New Directions begins today March 1, 2021 and is retroactive to treatments provided on or after January 22, 2021. The ability to treat Blue Cross HMO policyholders has created a significant increase in the number of clients ARIA has served since January 22, 2021. The facility has reached near capacity in its 18 PHP and IOP beds and has averaged between 50% and 75% of capacity in its detox and residential beds since it became an approved provider to New Directions. Blue Cross Blue Shield is the largest seller of health insurance in Florida. ARIA will begin construction March 1, 2021 on its first floor PHP, IOP and OP offices which will provide more bed space on its second and third floors which will increase capacity from 40 beds to 52 Beds. This capacity will be required to meet the demand of the Florida Blue policyholders. About Ethema Health Corporation Ethema Health Corporation (OTCPINK: GRST) operates in the behavioral healthcare space specifically in the treatment of substance use disorders. Ethema developed a unique style of treatment over the last decade and has had much success with in-patient treatment for adults. Ethema will continue to develop world class programs and techniques for North America. For more information you can visit our website at www.ethemahealth.com. Notice Regarding Forward-Looking Statements The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. For information please contact:Ethema Health CorporationText to 416-500-0020shawn@ethemahealth.com Twitter @healthethema